Clinical Trial-The Safety and Efficiency of γδ T Cell Against Liver Cancer-Liver Cancer

In this study, effects of γδT cells on human Liver Cancer in combination with tumor reducing surgery, for example, cryosurgery going to be investigated.A liver tumor will be removed using tumor reducing surgery such as cryosurgery.PBMC of the patient will be separated from peripheral blood. After making them potential cancer killer γδ T Cell and DC-CIK, they will be infused to the patients as an immunotherapy treatment.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: γδ T Cell Immunotherapy for Treatment of Liver Cancer
Anticipated Study Start Date : June 15, 2017
Estimated Primary Completion Date : January 15, 2018
Estimated Study Completion Date : June 15, 2020
Contacts
Contact: Mohammed Alnaggar, Post Doc 13826185510 dralnaggar@163.com
Locations
China, Guangdong
Biotherapy center in Fuda cancer hospital Recruiting
Guangzhou, Guangdong, China, 510665
ClinicalTrials.gov Identifier: NCT03183219

Add a Comment

Your email address will not be published. Required fields are marked *

One Comment